Genetics of redox systems and their relationship with cardiovascular disease
Dan Farbstein1, Yitzchak Z Soloveichik, Nina S Levy
1The Ruth and Bruce Faculty of Medicine, Technion Israel Institute of Technology, Efron St., POB 9649, Haifa 31096, Israel. dfarb@tx.technion.ac.il
Insights
Identifying genetic variations linked to oxidative stress is key for early cardiovascular disease (CVD) risk assessment. This study examines six key gene polymorphisms impacting CVD risk, protein function, and potential pharmacogenetics.
Area of Science:
- Genetics and Cardiovascular Medicine
- Molecular Biology and Disease Mechanisms
Background:
- Atherosclerosis remains a leading cause of mortality in Western populations.
- Oxidative stress is recognized as a critical factor in atherosclerosis development and progression.
- Genetic polymorphisms in redox-related genes are investigated for their association with cardiovascular disease (CVD) risk.
Purpose of the Study:
- To evaluate the impact of six specific gene polymorphisms on CVD risk.
- To analyze the effects of these polymorphisms on protein expression and function.
- To discuss the pharmacogenetic implications associated with these genetic variations.
Main Methods:
- Review and analysis of existing studies on six selected gene polymorphisms.
- Examination of data linking polymorphisms to CVD risk across different trials.
- Assessment of polymorphism effects on protein expression and functional activity.
Main Results:
- A limited number of polymorphisms consistently show relevance to CVD risk.
- Specific polymorphisms influence protein expression and function, contributing to disease risk.
- Pharmacogenetic data, where available, highlights potential treatment implications.
Conclusions:
- Certain gene polymorphisms related to redox systems are significantly associated with cardiovascular disease risk.
- Understanding these genetic factors can aid in identifying high-risk individuals for early intervention.
- Further research into pharmacogenetics of these polymorphisms may personalize CVD treatment strategies.
Abstract:
As atherosclerosis is still one of the major causes of death in Western populations, it is important to identify those individuals who are at increased risk for the disease so that aggressive treatment may be administered as early as possible. Following the understanding that oxidative stress has a pivotal role in the development and progression of atherosclerosis, many polymorphisms in genes that are related to redox systems were examined for their association with increased risk for cardiovascular disease (CVD). Although many polymorphisms were studied, only a handful showed consistent relevance to CVD in different trials. This article focuses on six of these polymorphisms, examining their effect on the risk for CVD as well as their effect on protein expression and function. Reports regarding pharmacogenetic implications of these polymorphisms, where such exist, are discussed as well.
Related Concept Videos
Redox Reactions
Redox Reactions
Redox Equilibria: Overview
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
Oxidation and Reduction of Organic Molecules
The removal of an electron from a molecule, results in a...


